StockClub
TEVATeva Pharmaceutical Industries Limited$ --
Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

TEVA

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
17,257M USD
YoY +4.3%

Operating Income

bar_chart
2,157M USD
YoY +811.9%

Net Income

verified
1,410M USD
YoY +186.0%

EPS

pie_chart
1.23USD
YoY +184.8%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress11.4%Below Target
Revenue Progress4B
Revenue Forecast16.7B
Net Income Progress369M
Net Income Forecast3.2B

Income Statement Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
17,257
8,320
8,938
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
1,013
2,686
3,973
15,100
2,157
Interest expense
Income before tax
Income tax expense
Net income
916
1,238
-180
1,410

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.